Bristol Hospice Goes All-In on De Novos
Hospice News
JANUARY 26, 2024
Bristol Hospice has been a prolific buyer in the hospice M&A market, but the company is now leaning heavily into its de novo strategy. Bristol Hospice, which is backed by the private equity firm Webster Equity Partners, employs more than 3,000 staff in close to 80 locations across 18 states. We’ll do the same this year.
Let's personalize your content